Are you thinking about starting a GLP-1 medication? About 1 in 8 US adults have used GLP-1s to manage diabetes, treat heart ...

New research suggests GLP-1 drugs may improve liver and heart health even without major weight loss, reshaping how doctors ...

GLP-1 therapies continue to reshape chronic disease treatment, triggering regulatory updates, new clinical findings and intensifying competition across the pharmaceutical market. On Jan. 13, the FDA ...

In a new trial, people who switched to the experimental daily GLP-1 pill orforglipron were able to keep off most of the weight they had lost taking Wegovy or Zepbound. People who switched from Wegovy ...

Combat muscle loss with this 7-move routine.

As GLP‑1 drugs transform consumer diets in real time, food companies are racing to build products that nourish, satisfy and ...

GLP-1s are driving demand for smaller portions, due to reducing consumer appetites. Could this lead to smaller pack sizes? And if so, will companies be able to save money from reducing the size of ...

The health of state employees and MassHealth members “is on the line,” clinicians and patients warned on Tuesday, due to diminishing coverage for GLP-1 drugs for weight loss. The cries come against a ...

GLP-1 users are posting about side effects and symptoms not seen in clinical trials, including irregular periods, fatigue, chills, and hot flashes. Here’s what that may mean for patients.

A comprehensive meta-analysis of 91 clinical trials involving more than 100,000 patients showed no increased risk for suicidal ideation or other psychiatric adverse events with GLP-1 receptor agonist ...

The growth potential in the GLP-1 market could help healthcare stocks soar in value. Competition, however, is likely to be fierce. Many drugs offer comparable weight loss. Healthcare companies have ...